These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9469226)

  • 1. Uptake of drugs from topically applied anti-inflammatory preparations applied to racing animals.
    Thomas AD; Bowater IC; Vine JH; McLean JG
    Aust Vet J; 1997 Dec; 75(12):897-901. PubMed ID: 9469226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
    Kietzmann M; Meyer-Lindenberg A; Engelke A; Nolte I
    Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
    Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
    Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper salicylate and copper phenylbutazone as topically applied anti-inflammatory agents in the rat and horse.
    Auer DE; Ng JC; Seawright AA
    J Vet Pharmacol Ther; 1990 Mar; 13(1):67-75. PubMed ID: 2319637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of topically applied dimethyl sulfoxide gel on endotoxin-induced synovitis in horses.
    Smith G; Bertone AL; Kaeding C; Simmons EJ; Apostoles S
    Am J Vet Res; 1998 Sep; 59(9):1149-52. PubMed ID: 9736394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case study of illicit preparation of antirheumatic analgesic with phenylbutazone as active ingredient.
    Thuan CE; Huat LB
    Med J Malaysia; 1989 Jun; 44(2):160-6. PubMed ID: 2626126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses.
    Knych HK; Stanley SD; Seminoff KN; McKemie DS; Kass PH
    J Vet Pharmacol Ther; 2016 Oct; 39(5):469-77. PubMed ID: 26924025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses.
    Lees P; Toutain PL
    Vet J; 2013 Jun; 196(3):294-303. PubMed ID: 23721873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
    Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
    Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses.
    Burkett BN; Thomason JM; Hurdle HM; Wills RW; Fontenot RL
    Vet Surg; 2016 Nov; 45(8):1087-1094. PubMed ID: 27731498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and urinary excretion of phenylbutazone in normal and febrile greyhounds.
    Mills PC; Ng JC; Hrdlicka J; Auer DE
    Res Vet Sci; 1995 Nov; 59(3):261-6. PubMed ID: 8588103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.